Capital Fund Management S.A. Edwards Lifesciences Corp Transaction History

Capital Fund Management S.A.

$36 Billion
Q3 2024

A detailed history of Capital Fund Management S.A. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Capital Fund Management S.A. holds 519,303 shares of EW stock, worth $35.2 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

519,303

Previous 35,656 1356.43%

Holding current value

$35.2 Million

Previous $3.29 Million 940.63%

% of portfolio

0.1%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$59.7 - $93.78 $28.9 Million - $45.4 Million	483,647 Added 1356.43%	519,303 $34.3 Million
Q2 2024 Aug 13, 2024	BUY	$84.3 - $94.31 $3.01 Million - $3.36 Million	35,656 New	35,656 $3.29 Million
Q3 2023 Nov 14, 2023	SELL	$69.28 - $93.38 $2.28 Million - $3.07 Million	-32,891 Reduced 8.17%	369,493 $25.6 Million
Q2 2023 Aug 14, 2023	SELL	$81.41 - $94.33 $3.21 Million - $3.72 Million	-39,453 Reduced 8.93%	402,384 $38 Million
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $12.9 Million - $14.7 Million	174,136 Added 65.05%	441,837 $36.6 Million
Q4 2022 Feb 13, 2023	BUY	$68.3 - $87.44 $15.4 Million - $19.8 Million	225,879 Added 540.1%	267,701 $20 Million
Q3 2022 Nov 14, 2022	SELL	$82.37 - $107.29 $11.3 Million - $14.7 Million	-137,106 Reduced 76.63%	41,822 $3.46 Billion
Q2 2022 Aug 12, 2022	BUY	$86.5 - $128.27 $13.8 Million - $20.4 Million	159,065 Added 800.81%	178,928 $17 Million
Q1 2022 May 12, 2022	SELL	$101.96 - $128.34 $10.2 Million - $12.9 Million	-100,126 Reduced 83.45%	19,863 $2.34 Million
Q4 2021 Feb 10, 2022	BUY	$106.37 - $130.68 $10.2 Million - $12.5 Million	95,744 Added 394.9%	119,989 $15.5 Million
Q3 2021 Nov 12, 2021	SELL	$102.91 - $122.75 $8.48 Million - $10.1 Million	-82,361 Reduced 77.26%	24,245 $2.74 Million
Q2 2021 Aug 12, 2021	SELL	$83.84 - $104.76 $22 Million - $27.5 Million	-262,903 Reduced 71.15%	106,606 $11 Million
Q1 2021 May 14, 2021	BUY	$78.68 - $90.67 $4.27 Million - $4.93 Million	54,328 Added 17.24%	369,509 $30.9 Million
Q4 2020 Feb 12, 2021	BUY	$71.69 - $91.23 $13.8 Million - $17.6 Million	192,730 Added 157.39%	315,181 $28.8 Million
Q3 2020 Nov 13, 2020	SELL	$67.19 - $87.44 $17.8 Million - $23.1 Million	-264,320 Reduced 68.34%	122,451 $9.77 Million
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $13.2 Million - $17.6 Million	228,923 Added 145.03%	386,771 $26.7 Million
Q1 2020 May 13, 2020	BUY	$52.41 - $81.0 $1.71 Million - $2.64 Million	32,622 Added 26.05%	157,848 $9.92 Million
Q4 2019 Feb 13, 2020	BUY	$71.7 - $82.09 $7.8 Million - $8.93 Million	108,803 Added 662.5%	125,226 $29.2 Million
Q3 2019 Nov 13, 2019	SELL	$61.55 - $75.43 $589,710 - $722,694	-9,581 Reduced 36.84%	16,423 $3.61 Million
Q4 2017 Feb 09, 2018	BUY	$33.79 - $39.39 $878,675 - $1.02 Million	26,004	26,004 $2.93 Million

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Capital Fund Management S.A. with notifications on news.

Account

Capital Fund Management S.A. Edwards Lifesciences Corp Transaction History